Winston Tan Selected Research

Winston Tan Research Topics

Disease

26	Prostatic Neoplasms (Prostate Cancer) 12/2022 - 09/2005
17	Neoplasms (Cancer) 01/2022 - 03/2003
7	Breast Neoplasms (Breast Cancer) 06/2022 - 01/2010
3	Neoplasm Metastasis (Metastasis) 12/2022 - 08/2017
3	Circulating Neoplastic Cells 01/2018 - 08/2017
3	Carcinoma (Carcinomatosis) 10/2015 - 03/2003
2	Cardiotoxicity 06/2022 - 04/2022
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2016 - 12/2013
2	Diarrhea 02/2007 - 03/2003
1	Disease Progression 02/2021
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2021
1	Body Weight (Weight, Body) 01/2020
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Colorectal Neoplasms (Colorectal Cancer) 01/2020
1	Weight Gain 01/2020
1	Osteonecrosis (Kienbock's Disease) 02/2019
1	Ductal Carcinoma 06/2018
1	Multiple Myeloma 01/2018
1	Obstructive Sleep Apnea 01/2017
1	Binge Drinking 05/2014
1	Inflammation (Inflammations) 01/2014
1	Hemorrhage 02/2007
1	Sleep Initiation and Maintenance Disorders (Insomnia) 03/2003
1	Nausea 03/2003
1	Fatigue 03/2003
1	Abdominal Pain (Pain, Abdominal) 03/2003

Drug/Important Bio-Agent (IBA)

7	Androgen Receptors (Androgen Receptor)IBA 11/2021 - 07/2014
7	AndrogensIBA 02/2021 - 03/2003
6	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
5	Hormones (Hormone)IBA 12/2022 - 03/2003
5	Cell-Free Nucleic AcidsIBA 01/2021 - 01/2018
4	Biomarkers (Surrogate Marker)IBA 06/2022 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 12/2020 - 01/2018
3	Trastuzumab (Herceptin)FDA Link 06/2022 - 01/2016
3	abirateroneIBA 01/2022 - 07/2014
3	Prostate-Specific Antigen (Semenogelase)IBA 02/2021 - 03/2003
3	Abiraterone AcetateIBA 02/2021 - 08/2017
3	Circulating Tumor DNAIBA 01/2021 - 04/2020
3	RNA (Ribonucleic Acid)IBA 01/2020 - 08/2017
2	AnthracyclinesIBA 06/2022 - 04/2022
2	Transcription Factors (Transcription Factor)IBA 11/2021 - 08/2017
2	Prednisone (Sone)FDA LinkGeneric 02/2021 - 12/2020
2	big gastrinIBA 01/2021 - 01/2020
2	Estrogen ReceptorsIBA 01/2020 - 10/2015
2	Messenger RNA (mRNA)IBA 01/2020 - 08/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2018
2	Tyrosine Kinase InhibitorsIBA 02/2019 - 12/2013
2	Antineoplastic Agents (Antineoplastics)IBA 02/2019 - 03/2003
2	Immune Checkpoint InhibitorsIBA 02/2019 - 10/2016
2	Progesterone Receptors (Progesterone Receptor)IBA 06/2018 - 10/2015
1	ParaffinIBA 06/2022
1	Type 1 Angiotensin ReceptorIBA 06/2022
1	Endothelin-1 (Endothelin 1)IBA 06/2022
1	AnthraquinonesIBA 04/2022
1	pixantrone (BBR 2778)IBA 04/2022
1	IronIBA 04/2022
1	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2022
1	Aligeron (AS 2)IBA 01/2022
1	SphingolipidsIBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	LipidsIBA 01/2022
1	Factor V (Coagulation Factor V)IBA 11/2021
1	Biological ProductsIBA 02/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Radium-223IBA 01/2021
1	atezolizumabIBA 01/2021
1	CeramidesIBA 01/2021
1	Progesterone FDA LinkGeneric 01/2020
1	Nucleic AcidsIBA 03/2019
1	TOR Serine-Threonine KinasesIBA 02/2019
1	human ERBB2 proteinIBA 06/2018
1	Chromogranin AIBA 01/2018
1	LigandsIBA 08/2017
1	SuspensionsIBA 01/2017
1	durvalumabIBA 10/2016
1	Monoclonal AntibodiesIBA 10/2016
1	5-alpha Reductase InhibitorsIBA 01/2016
1	Estrogens (Estrogen)FDA Link 10/2015
1	MicroRNAs (MicroRNA)IBA 01/2015
1	Dihydrotestosterone (Androstanolone)IBA 07/2014
1	enzalutamideIBA 07/2014
1	LipopolysaccharidesIBA 01/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2013
1	pazopanib FDA Link 12/2013
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	tanespimycin (17AAG)IBA 12/2008
1	Rifabutin (Ansamycin)FDA Link 12/2008
1	quinone (benzoquinone)IBA 12/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2008
1	LycopeneIBA 02/2007
1	TeaIBA 03/2003

Therapy/Procedure

19	Therapeutics 06/2022 - 03/2003
14	Castration 01/2022 - 07/2014
8	Drug Therapy (Chemotherapy) 06/2022 - 01/2016
2	Complementary Therapies (Alternative Medicine) 01/2022 - 02/2007
1	Cystectomy 10/2015
1	Tobacco Use Cessation Devices 05/2014
1	Adjuvant Chemotherapy 01/2010